A phase I trial of recombinant human interleukin-1β(OCT-43) following high-dose chemotherapy and autologous bone marrow transplantation. - Elkordy, M; Crump, M; Vredenburgh, J J; Petros, W P; Hussein, A; Rubin, P; Ross, M; Gilbert, C; Modlin, C; Meisenberg, B; Coniglio, D; Rabinowitz, J; et al. (Bone Marrow Transplantation, 1997)